This randomized clinical trial explores whether dynamic psychotherapy is not inferior to cognitive therapy in the treatment of major depressive disorder among adults treated in a community mental health center.
This randomized clinical trial examines the relative efficacy of weight-adjusted d-cycloserine (25 or 50 mg) vs placebo augmentation of cognitive behavior therapy for youth with obsessive-compulsive disorder and assesses if concomitant antidepressant medication moderated effects.
This randomized clinical trial reports that web-based cognitive behavioral therapy is associated with a reduced likelihood of suicidal ideation among medical interns.
This randomized clinical trial compares the efficacy of cognitive behavioral group psychotherapy vs individual clinical management and methylphenidate vs placebo in patients with adult attention-deficit/hyperactivity disorder.
This meta-analysis examines baseline depression severity as a moderator of treatment outcomes between cognitive behavioral therapy and antidepressant medication.
This randomized clinical trial determines whether a cognitive-behavioral prevention program can reduce the incidence of depressive episodes, increase depression-free days, and improve developmental competence 6 years after implementation among at-risk adolescents.
This randomized clinical trial examines the effects of telephone-delivered cognitive-behavioral therapy compared with telephone-delivered nondirective supportive therapy in rural older adults with generalized anxiety disorder.
This randomized clinical trial examines whether d-cycloserine augments cognitive behavioral therapy in the treatment of obsessive-compulsive disorder (OCD) and whether concomitant use of antidepressants moderates the effects of d-cycloserine.
This randomized clinical trial in patients with comorbid adult attention-deficit/hyperactivity disorder (ADHD) and cocaine use disorder examined whether extended-release mixed amphetamine salts are effective for both improving symptoms of ADHD and reducing cocaine use.
This longitudinal study determines that response to cognitive behavioral therapy (CBT) can be predicted on an individual-patient level based on functional neuroimaging data in panic disorder and agoraphobia.
This randomized clinical trial reports that problem adaptation therapy was more efficacious than supportive therapy for cognitively impaired patients in reducing depression and disability. Problem adaptation therapy may provide relief to a large group of depressed and cognitively impaired older adults with few treatment options.
This quasi-experimental study shows that a mental health intervention integrated into an employment training program can reduce depressive symptoms and improve engaged coping strategies in adolescents and young adults.
This randomized clinical trial shows that cognitive behavior therapy that includes exposure therapy to treat prolonged grief disorder facilitates emotional responses that reduce symptoms.
In a 2-center, randomized, controlled, assessor-blind, parallel group trial, Moritz and coauthors examine the long-term efficacy of group metacognitive training for schizophrenia in order to explore whether previously established effects were sustained.